{{Rsnum
|rsid=17680137
|Gene=SLCO1B3
|Chromosome=12
|position=20862972
|Orientation=plus
|GMAF=0.07805
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene_s=SLCO1B3
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 65.6 | 31.2 | 3.1
| HCB | 97.8 | 2.2 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 100.0 | 0.0 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 97.8 | 2.2 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs17680137
|Name_s=
|Gene_s=SLCO1B3
|Feature=
|Evidence=PubMed ID:19419973
|Annotation=This variant is in intron 7 of SLCO1B3 gene and associated with bilirubin levels and unconjugated hyperbilirubinemia in a genome wide association scan from 4300 Sardinian individuals.
|Drugs=
|Drug Classes=
|Diseases=Hyperbilirubinemia
|Curation Level=Curated
|PharmGKB Accession ID=PA164758018
}}

{{PMID Auto
|PMID=20639394
|Title=Genome-wide association of serum bilirubin levels in Korean population
|OA=1
}}

{{omim
|id=601816
|rsnum=17680137
}}

{{PMID Auto
|PMID=22580719
|Title=UGT1A1, SLCO1B1, and SLCO1B3 polymorphisms versus neonatal hyperbilirubinemia: is there an association?
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs17680137
|overall_frequency_n=13
|overall_frequency_d=128
|overall_frequency=0.101562
|n_genomes=9
|n_genomes_annotated=0
|n_haplomes=11
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | Affy GenomeWide 6}}